Mankind Pharma Announces Participation in 2026 Jefferies Global Healthcare Conference in London from November 16-19
Company officials to engage in one-on-one and group investor meetings without disclosing unpublished price sensitive information
Mankind Pharma announces its participation in the 2026 Jefferies Global Healthcare Conference scheduled from November 16 to 19, 2026, in London, involving one-on-one and group meetings with investors and analysts. The company confirms no unpublished price sensitive information will be shared during these engagements, focusing only on publicly available general business outlooks.
Mankind Pharma Limited
Investor Presentation
Mankind Pharma has confirmed that company officials will participate in the 2026 Jefferies Global Healthcare Conference in London from November 16 to 19, 2026, conducting one-on-one and group meetings with investors and analysts.
The company stated that no unpublished price sensitive information will be disclosed during these meetings, which will be based solely on the general business outlook and information already available in the public domain.
The schedule of participation is subject to change depending on exigencies from either party.
Details of this participation have been uploaded on Mankind Pharma’s official website for transparency and investor information.
Highlights
- Participation in 2026 Jefferies Global Healthcare Conference from November 16-19, 2026
- Location: London
- Meeting type: One-on-One and Group Meetings with investors and analysts
- No unpublished price sensitive information will be shared
- Company confirms schedule may change due to exigencies
- Participation details available on www.mankindpharma.com
Key Data Snapshot
What happened
- Mankind Pharma officials will participate in the 2026 Jefferies Global Healthcare Conference in London between November 16 and 19, 2026.
- The company plans to hold one-on-one and group meetings with investors and analysts during the conference.
Key details
- No unpublished price sensitive information will be disclosed during investor interactions, restricted to general business outlook and publicly available data.
- The schedule of the conference and company participation is subject to change due to possible exigencies on either side.
- Information regarding participation has been made publicly available through the company's website.
Highlights
- Participation in 2026 Jefferies Global Healthcare Conference from November 16-19, 2026
- Location: London
- Meeting type: One-on-One and Group Meetings with investors and analysts
- No unpublished price sensitive information will be shared
- Company confirms schedule may change due to exigencies
- Participation details available on www.mankindpharma.com
Disclosures
- Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
Lord's Mark Industries Conducts Investor Call on Business Progress, Shares Audio and Video Recordings Online
Lord's Mark Industries Limited held an investor conference call on 19th November 2026 to update stakeholders on the company’s business progress and operational developments. Following SEBI regulations, the company has made audio and video recordings of the call accessible on its website.
Read Full StoryUrban Company to Hold Virtual Analyst and Investor Meeting with Major Asset Managers on November 25, 2026
Urban Company Limited has arranged a virtual group meeting with key asset management firms on November 25, 2026, providing an opportunity for investor engagement without sharing unpublished price-sensitive information.
Read Full StoryTata Technologies Publishes Investor Day 2026 Presentations Detailing Strategic Growth Focus and Innovation
Tata Technologies Limited has made available video recordings of its Investor Day held on November 19, 2026. These presentations cover comprehensive insights into the company's strategic initiatives and operational priorities across key areas for growth and innovation.
Read Full Story